CREB1 and breast carcinoma: Breast cancer cells (ZR75.1) treated with Ti-EVs derived from cancer-associated adipose had a higher degree of phosphorylation of cAMP response element-binding protein (CREB) serine residue 133, indicating that Ti-EVs can promote the breast cancer cell proliferation (Jeurissen et al. 2017).